<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>108-CALCITONIN.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="CALCITONIN" rxcui="36118">
<ATC code="H05BA" />
<ATC code="H05BA03" />
<ATC code="H05BA02" />
<ATC code="H05BA01" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="LITHIUM" rxcui="6448">
<ATC code="D11AX04" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of reduction of the effectiveness of the lithium due to increase of its renal elimination by the calcitonin</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Regular clinical and biological monitoring, especially at the beginning of the administration of the two substances together.</COMMENT>
</INTERACTION>
</INTERACTIONS>
